Nature Communications (Aug 2022)

SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells

  • Eva M. Stevenson,
  • Sandra Terry,
  • Dennis Copertino,
  • Louise Leyre,
  • Ali Danesh,
  • Jared Weiler,
  • Adam R. Ward,
  • Pragya Khadka,
  • Evan McNeil,
  • Kevin Bernard,
  • Itzayana G. Miller,
  • Grant B. Ellsworth,
  • Carrie D. Johnston,
  • Eli J. Finkelsztein,
  • Paul Zumbo,
  • Doron Betel,
  • Friederike Dündar,
  • Maggie C. Duncan,
  • Hope R. Lapointe,
  • Sarah Speckmaier,
  • Nadia Moran-Garcia,
  • Michelle Premazzi Papa,
  • Samuel Nicholes,
  • Carissa J. Stover,
  • Rebecca M. Lynch,
  • Marina Caskey,
  • Christian Gaebler,
  • Tae-Wook Chun,
  • Alberto Bosque,
  • Timothy J. Wilkin,
  • Guinevere Q. Lee,
  • Zabrina L. Brumme,
  • R. Brad Jones

DOI
https://doi.org/10.1038/s41467-022-32376-z
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 15

Abstract

Read online

Here, the authors show in a cohort of people with HIV, COVID mRNA vaccination is followed by a transient boost in a particular profile of HIV-specific T-cell responses and a corresponding decrease in residual HIV RNA – suggesting productive immune engagement with infected cells.